Atrial appendage anomaly is a heart condition that affects the small pouch-like areas attached to the upper chambers. People with atrial appendage anomaly may have no symptoms, or they may notice palpitations, shortness of breath, or fatigue during activity. It can increase the risk of blood clots and stroke over time, so doctors often focus on prevention and monitoring. Many living with atrial appendage anomaly are diagnosed in adulthood, and care may include blood thinners, heart rhythm medicines, or procedures to close or remove the appendage. The outlook varies, but with timely treatment and stroke prevention, many people live long and full lives.
Overview
Atrial appendage anomalySymptoms
Many people with atrial appendage anomaly have no noticeable symptoms. When present, early symptoms of atrial appendage anomaly can include heart fluttering or palpitations, shortness of breath, chest discomfort, dizziness, fainting, or stroke-like episodes from blood clots.
Outlook and prognosis
Many living with atrial appendage anomaly do well, especially when it’s found early and monitored. Risk often depends on the specific anatomy and whether rhythm problems or clots develop. With tailored care—anticoagulation, rhythm control, or surgery—most maintain good quality of life.
Causes and risk factors
Atrial appendage anomaly may be present from birth or develop with heart strain. Contributors include long‑standing high blood pressure, valve disease, atrial fibrillation, and inflammation. Risks rise with congenital heart disease, family history, advancing age, obesity, smoking, and prenatal exposures.
Genetic influences
Genetics plays a meaningful role in atrial appendage anomaly, though not all cases are inherited. Variants in heart‑development genes can influence structure, rhythm risks, and clot tendency. Family history may guide screening; genetic counseling is sometimes recommended.
Diagnosis
Clinicians suspect atrial appendage anomaly from exam, then confirm with imaging—usually echocardiogram, sometimes CT or MRI. ECG checks rhythm problems. Genetic tests may be offered if a syndrome is suspected; diagnosis of atrial appendage anomaly relies on imaging.
Treatment and drugs
Treatment for atrial appendage anomaly focuses on lowering stroke risk and treating rhythm problems. Care may include blood thinners, medicines to steady the heartbeat, catheter procedures or device closure of the appendage, and sometimes surgery. Choices depend on your anatomy, symptoms, and overall risk.
Symptoms
Atrial appendage anomaly can be silent; many people only learn about it during a heart scan for another reason. Early symptoms of atrial appendage anomaly often relate to irregular heart rhythms or blood flow changes—things like fluttering in the chest, shortness of breath, lightheadedness, or stroke-like symptoms. Symptoms vary from person to person and can change over time. What you feel depends on the specific issue and whether it affects heart rhythm, breathing, or circulation.
Many people with atrial appendage anomaly have no noticeable problems, and the finding shows up on a heart scan done for another reason. Routine checkups or imaging for another issue may be when it’s first spotted.
Fluttering, pounding, or a skipped-beat feeling in your chest can come and go. This often reflects an irregular rhythm, which may feel stronger during exercise, stress, or after caffeine. This can be an early sign in atrial appendage anomaly when irregular rhythms are involved.
A fast, slow, or uneven pulse can cause chest unsteadiness and worry. In medical terms, this is an arrhythmia; in everyday life, it shows up as unpredictable beats or flutters.
Feeling winded with stairs or light activity can happen if the heart isn’t filling or pumping smoothly. Some notice they need extra pillows at night to breathe comfortably.
How people usually first notice Atrial appendage anomaly?
Many people first notice an atrial appendage anomaly when a routine test for another issue—like an ECG, echocardiogram, or heart imaging before surgery—picks up an unusual structure or flow pattern in the heart. In some, the first signs are symptoms linked to irregular heart rhythms or blood clots, such as palpitations, shortness of breath, chest discomfort, fainting, or a stroke-like event (sudden weakness, trouble speaking), prompting urgent evaluation. In babies and children, doctors may first recognize it on prenatal ultrasound or early-life echocardiograms done for a heart murmur, poor feeding, bluish skin (cyanosis), or growth concerns.
Types of Atrial appendage anomaly
Atrial appendage anomaly can mean different structural differences in the small pouches attached to the heart’s upper chambers, and those differences can change clot risk, rhythm issues, and how treatments are planned. Not everyone will experience every type. Clinicians often describe them in these categories: types of atrial appendage anomaly linked to the left side, the right side, or both.
Left atrial appendage anomaly
Changes in the left pouch can raise the chance of clots and stroke, especially if atrial fibrillation is present. Symptoms may be silent or include palpitations and shortness of breath. Imaging guides decisions such as blood thinners or closure devices.
Right atrial appendage anomaly
Differences in the right pouch are less often tied to stroke but can relate to rhythm problems or rare clots that travel to the lungs. Many people have no symptoms, while some notice fluttering or reduced exercise tolerance. Echocardiography or cardiac MRI helps confirm the shape and size.
Bilateral appendage anomalies
Both pouches are affected, which can compound rhythm issues and overall clot risk depending on the exact shapes. People may notice episodes of fast, irregular beats or fatigue during everyday activities. Care usually focuses on rhythm control and stroke prevention tailored to imaging findings.
What genetics can tell you about symptoms
Some people with atrial appendage anomalies inherit changes in heart‑building genes, which can alter the size or shape of the atrial appendage. This may lead to palpitations, shortness of breath, fatigue, or blood clots that increase stroke risk.
Causes and risk factors
Atrial appendage anomaly often starts with a genetic change present from conception, inherited or new, that affects early heart formation. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Risk factors for atrial appendage anomaly during pregnancy include poorly controlled diabetes, certain infections, alcohol or tobacco use, and some medicines or toxins. Family history of congenital heart disease, certain genetic syndromes, and older maternal age can raise the chance. In rare cases, similar appendage changes can be acquired later from long-standing high blood pressure, valve disease, or abnormal heart rhythms.
Environmental and biological risk factors
During pregnancy, certain exposures and parent health factors can raise the chance of differences in the small heart pouches that help with blood flow—this is known medically as an atrial appendage anomaly. Even when early symptoms of atrial appendage anomaly are hard to spot, understanding what can raise the odds can help with planning. Doctors often group risks into internal (biological) and external (environmental). Below are factors linked with a higher likelihood during early heart development.
Pre‑existing diabetes that is not well controlled early in pregnancy can affect how the fetal heart forms. High blood sugars can disrupt the signals that shape small heart structures like the appendages.
If phenylketonuria (PKU) in the mother is not well controlled before and during early pregnancy, high phenylalanine can harm heart development. This raises the chance of structural differences in the baby’s heart.
Rubella infection in the first trimester can interfere with normal heart formation. The virus can affect blood vessel and valve development that sit near the atrial appendages.
Early pregnancy exposure to vitamin A–based acne medicines, some anti‑seizure drugs, lithium, or certain blood thinners has been linked with congenital heart differences. Risk depends on the specific drug, dose, and timing of exposure.
Genetic risk factors
Atrial appendage anomaly can run in families or appear as part of broader genetic patterns that shape how the heart forms before birth. Some risk factors are inherited through our genes. The genetic causes of atrial appendage anomaly often trace back to changes in genes that direct left–right body patterning or early heart development. In some people, the change is new in the child rather than inherited.
Laterality disorders: Changes in genes that set the body’s left–right layout can make both atrial appendages develop with similar features. This pattern, sometimes called atrial isomerism, is a common genetic pathway to atrial appendage anomaly.
Cilia gene variants: Gene changes that affect tiny, hair‑like cell structures (cilia) can disrupt left–right signaling in early development. This raises the chance of atrial appendage differences; examples include DNAH5, DNAH11, and related cilia genes.
ZIC3 changes: Variants in the ZIC3 gene can cause an X‑linked form of laterality differences. This may affect multiple organs and can include unusual atrial appendage shape or symmetry.
Heart‑forming genes: Subtle changes in genes that guide early heart development, such as NKX2‑5, GATA4, or TBX5, can alter the atria’s shape and muscle pattern. For some, this contributes to atrial appendage anomaly alongside septal or rhythm differences.
Copy‑number variants: Missing or extra stretches of DNA (CNVs), including regions like 22q11.2 or 1p36, increase overall risk for congenital heart differences. In some cases, these broader changes may involve the atrial appendages.
Syndromic conditions: Genetic syndromes that include heart and other body differences can feature atypical atrial appendages as part of the picture. The exact heart features vary widely between people and even within the same family.
Familial CHD history: Having a close relative with congenital heart disease signals a higher inherited predisposition, even when no single gene is identified. The specific heart finding may differ from one family member to another.
De novo variants: Sometimes the genetic change arises new in the child and is not present in either parent. These new variants can still lead to atrial appendage anomaly without any prior family history.
Lifestyle risk factors
Lifestyle habits do not cause atrial appendage anomalies, but they can shape how symptoms unfold and how complications like atrial fibrillation and blood clots develop. Understanding how lifestyle affects Atrial appendage anomaly can help reduce rhythm triggers and clot risk alongside medical care. Below are lifestyle risk factors for Atrial appendage anomaly you can review with your clinician.
Binge or frequent alcohol can trigger atrial fibrillation, increasing blood stagnation in the appendage and clot risk. Limiting intake may reduce arrhythmia episodes and stroke risk.
Excess salt can raise blood pressure and atrial stretch, potentially worsening appendage dilation and rhythm instability. Choosing lower-sodium meals can ease cardiac strain and lower arrhythmia risk.
Long periods of sitting slow circulation and can raise venous and atrial stasis, increasing clot formation risk in a vulnerable appendage. Regular light movement breaks support better blood flow.
Low fluid intake thickens blood and can promote clotting within the atrial appendage. Steady hydration helps maintain blood viscosity and flow.
Risk prevention
Atrial appendage anomaly is usually present from birth, so you can’t fully prevent the condition itself. Prevention focuses on lowering risks linked to it, like blood clots, stroke, and heart rhythm problems. Your plan will depend on the exact type of anomaly and whether you have symptoms or other heart issues. Prevention works best when combined with regular check-ups.
See a cardiologist regularly to track any changes and adjust your plan. Consistent care helps catch clot risks or rhythm issues early.
Your team may suggest periodic echocardiograms or cardiac MRI to watch the atrial appendage. Imaging helps decide if medicines or procedures are needed.
If your stroke risk is high, doctors may recommend an anticoagulant or antiplatelet medicine. Taking it exactly as prescribed helps prevent clots linked to atrial appendage anomaly.
Wearable monitors or periodic ECGs can catch silent atrial fibrillation or flutter. Treating rhythm problems lowers stroke risk and symptoms like palpitations.
Transmission
Atrial appendage anomaly is not an infection and cannot be passed from person to person. It is a congenital heart difference present from birth; in many people it happens as a one-time change during early development, while in some families it can be linked to gene changes or be part of a broader genetic syndrome. When it is inherited, the pattern can vary, so discussing the genetic transmission of atrial appendage anomaly with a genetics professional can clarify risks for future pregnancies and relatives. Most people with this condition have no clear cause identified, but if you or your child has it, a family history review and, at times, genetic testing can help explain how atrial appendage anomaly is inherited.
When to test your genes
Consider genetic testing if you were diagnosed young, have recurrent arrhythmias or unexplained stroke, or there’s a family history of atrial defects, sudden cardiac death, or clotting events. Testing also helps when imaging shows atypical atrial anatomy and your care team is choosing procedures or anticoagulation. A genetics referral guides timing, test type, and results.
Diagnosis
For many, the first step comes when everyday activities start feeling harder, like new flutters in the chest or breathlessness with stairs, while others learn about it by chance during a heart scan for something else. The diagnosis of atrial appendage anomaly usually relies on heart imaging to confirm the shape, size, and position of the small pouch attached to the atrium. Symptoms, health history, and any stroke-like events help guide which tests come first. For some, routine check-ups reveal the first clues.
Providers review symptoms such as palpitations, shortness of breath, chest discomfort, or a past mini-stroke. They combine your story with a focused exam to decide which heart imaging makes the most sense next.
This ultrasound through the chest wall is often the first look at the atrial appendage. It can suggest an atrial appendage anomaly and assess heart function, though small details may be hard to see.
An ultrasound probe in the esophagus gives a close view of the left atrial appendage. It helps confirm the anatomy, spot clots, and clarify findings when the standard echo is unclear.
CT creates detailed 3D pictures to define the appendage’s shape, size, and any outpouching or unusual position. It can also help detect clots or narrowing of nearby structures.
Stages of Atrial appendage anomaly
Atrial appendage anomaly does not have defined progression stages. It’s a structural difference in the small heart pouch that is usually present from birth, and its impact depends on the specific pattern and any complications, rather than a step-by-step worsening. Different tests may be suggested to help confirm the anatomy and understand clot or rhythm risks, such as an echocardiogram, transesophageal echo, CT, or cardiac MRI. How doctors diagnose atrial appendage anomaly typically involves echocardiography reviewed by a cardiologist, with follow-up imaging to monitor changes or guide treatment if needed.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially when atrial appendage anomaly is first found on an echo or during an evaluation for palpitations. For many, the outlook depends on the exact shape and size of the appendage and whether blood flow becomes sluggish inside it. Some people never develop symptoms and are monitored over time; others may notice shortness of breath with stairs, brief fluttering in the chest, or fatigue during a cold or after a heavy meal. Doctors call this the prognosis—a medical word for likely outcomes.
Looking at the long-term picture can be helpful. The biggest risks with an atrial appendage anomaly are usually related to blood clots forming in a poorly emptying appendage and rhythm problems like atrial fibrillation. Because of this, early symptoms of atrial appendage anomaly such as new palpitations, lightheadedness, or reduced exercise tolerance deserve attention, since treating rhythm issues or adding blood-thinning medication can lower stroke risk. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
The outlook is not the same for everyone, but most people do well when the condition is found early and managed with the right mix of monitoring, medicines, and, when needed, procedures to close or remove a high‑risk appendage. If stroke risk is high and blood thinners aren’t a good fit, minimally invasive closure devices may reduce that risk; when needed for structural problems, surgery can be curative. Mortality from atrial appendage anomaly itself is low when clot risk and heart rhythm are controlled, though outcomes are more serious if strokes occur or if there are other heart conditions at the same time. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Living with atrial appendage anomaly over many years can mean dealing with rhythm changes and the risk of clots that may travel to the brain. Some remember early symptoms of atrial appendage anomaly as brief fluttering or shortness of breath, which may come and go before settling into clearer patterns. Long-term effects vary widely, and some people have only mild issues while others face recurrent events. Doctors often describe these as long-term effects or chronic outcomes.
Episodes of fast or uneven heartbeats can emerge or become more frequent with age. These may show up as atrial fibrillation or atrial flutter, bringing palpitations or lightheaded spells. For some, these rhythms remain occasional; for others, they recur.
Clots can form in the appendage and travel to the brain or body, causing stroke or transient symptoms. The lifetime risk depends on the anatomy and any coexisting heart issues. Atrial appendage anomaly can raise this risk compared with typical heart structure.
The pouch-like anatomy can slow blood flow, allowing clots to develop. Clots may be silent for long periods until they cause symptoms. Imaging sometimes uncovers them before any event occurs.
Shortness of breath, early fatigue, or chest tightness can limit activity over time. These changes may reflect long-standing rhythm issues or strain on the upper heart chambers. Day-to-day energy can fluctuate.
How is it to live with Atrial appendage anomaly?
Living with an atrial appendage anomaly can feel uneventful for many, especially if it’s found incidentally on imaging and causes no symptoms, but others may notice palpitations, fatigue, or brief lightheaded spells that make exercise or busy days harder to manage. Daily life often includes heart-healthy habits, staying hydrated, limiting alcohol, and keeping regular check-ins with a cardiologist; some people take blood thinners or rhythm medicines, which add routines like lab monitoring or mindful fall prevention. Partners, family, and coworkers may simply need to understand why you pace activities or avoid certain triggers, and to learn the signs of concerning symptoms so they can support you without hovering. With a clear care plan and awareness of your limits, most people continue school, work, travel, and family life with confidence.
Treatment and drugs
Treatment for atrial appendage anomaly depends on the exact shape problem, your symptoms, and your risk of clots or rhythm issues. Doctors often use blood thinners to lower stroke risk, and medicines that steady the heartbeat if irregular rhythms occur; a doctor may adjust your dose to balance benefits and side effects. Some people benefit from procedures that close or remove the left atrial appendage to prevent clots, or surgery to repair the appendage anatomy—especially if there’s another heart procedure planned. Imaging tests guide the plan, and follow-up is important to track clot risk and rhythm over time. Ask your doctor about the best starting point for you.
Non-drug treatment
Day to day, the focus is lowering stroke risk and preventing fast or irregular heartbeats. Alongside medicines, non-drug therapies can reduce risks and support heart rhythm during activity and rest. Because early symptoms of atrial appendage anomaly can be subtle, planned monitoring and, when needed, minimally invasive procedures are considered. Care is personalized based on the exact shape of the appendage and your overall health.
A small device can be placed through a vein to seal the left atrial appendage and lower clot-related stroke risk. This minimally invasive approach may be considered if long-term blood thinners are not a good fit.
Surgeons can repair, reduce, or remove an enlarged or fragile appendage to prevent clots or rhythm triggers. This is usually done during open-heart surgery or combined with another needed heart procedure.
Thin tubes are guided through blood vessels to burn or freeze tiny areas that spark abnormal rhythms. This can reduce atrial fibrillation or flutter that sometimes starts near the appendage.
Structured programs, like cardiac rehabilitation, can help you build safe endurance and confidence after a heart procedure. A supervised plan tailors exercise and education to your goals and medical needs.
Your genes may have an impact on how drugs work for you
Think of treatment like tuning a heart’s rhythm: the same dose can act differently because your genes shape how fast you process drugs and how sensitive your heart tissues are. Pharmacogenetic testing can guide choices and doses for anticoagulants and antiarrhythmics, reducing side effects.
Pharmacological treatments
Medicines focus on two goals: lowering clot and stroke risk and managing rhythm issues that can occur alongside the appendage. Choices depend on your clot risk, heart rhythm, kidney function, and bleeding history, and may change over time. Not everyone responds to the same medication in the same way. For atrial appendage anomaly, doctors may combine blood thinners with rate or rhythm medicines if atrial fibrillation is present.
Apixaban, rivaroxaban, dabigatran, and edoxaban lower the chance of clots forming in or near the appendage. They do not require regular INR blood checks, but kidney function and bleeding risk still need review. In atrial appendage anomaly with atrial fibrillation or high clot risk, these are often preferred.
This older blood thinner prevents stroke by blocking vitamin K–dependent clotting. It needs regular INR monitoring and dose changes to keep levels safe. Your clinician may choose it if you have a mechanical valve, severe kidney disease, or cost or access barriers to newer drugs.
Aspirin or clopidogrel may be used if full anticoagulation is not possible or after appendage procedures. These medicines do not treat early symptoms of atrial appendage anomaly; they mainly reduce platelet clumping. Stroke protection is generally weaker than with anticoagulants.
Metoprolol, diltiazem, verapamil, or digoxin help slow a fast heartbeat if atrial fibrillation or flutter occurs. This can ease breathlessness, palpitations, or fatigue in people with atrial appendage anomaly. Dose is tailored to blood pressure, activity level, and other heart conditions.
Genetic influences
Genetics can play a role in some atrial appendage anomaly cases, especially when the finding occurs alongside other heart differences present from birth. It’s natural to ask whether family history plays a role. Changes in genes that guide the heart’s left–right pattern and early formation can sometimes be involved and may run in families, though many people have no identifiable genetic change and the anomaly happens for the first time in them. If a parent, sibling, or child has a congenital heart defect, the chance of related features, including an atrial appendage anomaly, is higher than average but still low for most families, and even within one family the exact features can vary a lot. Genetic counseling and, in selected cases, genetic testing designed for congenital heart conditions can clarify recurrence risk and whether to screen for other organ or rhythm issues linked to the atrial appendage. While genetics can’t forecast the early symptoms of atrial appendage anomaly, results can help tailor monitoring and care plans over time.
Is Atrial appendage anomaly genetic?
Genetics plays a meaningful role in atrial appendage anomaly, though not all cases are inherited. Variants in heart‑development genes can influence structure, rhythm risks, and clot tendency. Family history may guide screening; genetic counseling is sometimes recommended.
Pharmacogenetics—how genetics influence drug effects
For people with atrial appendage anomaly, care often includes blood thinners to lower clot and stroke risk, and sometimes rhythm medicines or a closure procedure. Differences in your genes can change how you handle some of these drugs, which may affect the best dose or whether a different medication is safer. Warfarin is a clear example—certain gene patterns can make you more sensitive or slow its breakdown, so a lower starting dose and closer checks may be needed instead of a one‑size‑fits‑all plan. If a left atrial appendage occlusion device is used, short‑term antiplatelet therapy like clopidogrel may be prescribed; some people have gene changes that make clopidogrel work less well, in which case another antiplatelet may be preferred. Genetic testing can sometimes identify how your body processes warfarin or activates clopidogrel, which can guide the dose or suggest an alternative medication. Responses also depend on age, kidney function, and other medicines, and for direct oral anticoagulants the genetic influence is less clear, so pharmacogenetic testing for atrial appendage anomaly care is generally most helpful when decisions involve warfarin or clopidogrel.
Interactions with other conditions
People with atrial appendage anomaly often also live with rhythm problems like atrial fibrillation, and when these occur together the chance of blood clots and stroke can rise. To understand overall health, it’s useful to see how conditions overlap. High blood pressure, sleep apnea, and valve disease can enlarge or stiffen the upper chambers of the heart, which may make it harder for the appendage to empty fully and can push doctors to consider blood-thinning treatment. If someone already has a bleeding tendency, stomach ulcers, or kidney disease, decisions about anticoagulation for atrial appendage anomaly become more complex and call for careful balancing of clot versus bleeding risks. In congenital heart disease or cardiomyopathy, changes in heart structure can go hand in hand with an appendage that’s shaped or positioned differently, which may influence choices like a closure procedure or a heart rhythm treatment. For those who’ve had a prior stroke or TIA, early symptoms of atrial appendage anomaly may be subtle or absent, so teams may screen more closely when other risk factors are present.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of sudden shortness of breath or fainting during activity, sometimes after an illness, that doctors struggled to explain with the tools of the time. In homes and clinics, people with unusual heart rhythms were told they had a “weak heart,” yet their main heart chambers looked normal on early exams. Looking back helps explain why these stories were confusing: the small pouches attached to the atria—the atrial appendages—were hard to see with older imaging, so changes there often went unnoticed.
First described in the medical literature as unusual shapes or sizes of these appendages seen during surgery or at autopsy, atrial appendage anomaly gradually shifted from a curiosity to a recognized contributor to symptoms like palpitations, chest discomfort, or brief dizziness. As ultrasound of the heart (echocardiography) improved in the late 20th century, clinicians began to spot appendage enlargement, reduced movement, or abnormal connections in living patients. With each decade, cardiac MRI and CT added clearer pictures, helping teams connect early symptoms of atrial appendage anomaly—such as exercise intolerance or irregular beats—with what doctors could now see on scans.
From early theories to modern research, the story of atrial appendage anomaly shows how tools shape understanding. Early reports focused on dramatic cases, including rare congenital forms or surgical findings during repair of other heart conditions. Over time, descriptions became broader, recognizing that some people have mild changes that never cause problems, while others face rhythm issues or a higher risk of clots. This range helped explain why two relatives might share similar findings but very different day‑to‑day experiences.
Advances in genetics added another layer. In some families, researchers noticed clusters of heart structure differences, including the atrial appendages, alongside conduction or rhythm conditions. Not every early description was complete, yet together they built the foundation of today’s knowledge. Now, instead of discovering an anomaly only after a serious event, many are identified during routine heart scans, pre‑sports evaluations, or assessments before procedures.
Awareness has also grown in surgical and device planning. Surgeons and electrophysiologists began tailoring approaches—such as how to manage the left atrial appendage during rhythm procedures—based on each person’s anatomy. This practical experience fed back into the medical literature, refining definitions and risk assessments. Today, the history of atrial appendage anomaly reflects steady progress: from hidden structure to visible feature, from isolated case notes to guidelines that consider age, symptoms, and coexisting heart conditions. For many living with atrial appendage anomaly, this means clearer explanations, more precise imaging, and care plans that match the specific shape and function of their heart.